Antibiotics: SULF, CYCLINE, and (FL)OXACIN Flashcards
SULF (Sulfonamides)
- First effective chemotherapeutic agents used systemically for the prevention and cure of bacterial infections in humans (Prontosil (1932) => Nobel Prize in Medicine (1938))
- Development of penicillin (1940s) => diminished usefulness of
sulfonamides (except trimethoprim-sulfamethoxazole)
What is Sulfonamides drived from?
Para-aminobenzoic acid
MOA
Sulfonamides
Bacteriostatic
Competitive inhibitors of dihydropteroate synthase
- The bacterial enzyme responsible for incorporation of PABA into dihydropteroic acid, the immediate precursor of folic acid
- Competitive antagonism of PABA
Folic Acid Synthesis Inhibitor
SULF Types
Sulfamethoxazole
- Trimethoprim-Sulfamethoxazole (Bactrim, Septra, Cotrim): PO, and IV
Sulfadiazine: PO
Sulfacetamide: topical: cream, lotion, etc
Trimethoprim-Sulfamethoxazole (TMP-SMX)
Aka cotrimoxazole
- Wide variety of antimicrobial activity => range of clinical indications
Key spectrum of activity
- Staphylococcus aureus (including MRSA): Gram +
- E.coli, and other Enterobacteriaceae: Gram -
- Listeria monocytogenes (menagitis)
- Pneumocystitis jiroveci (most common)
- Taxoplasma gondii
- Nocaardia spp.
- Stenotrophomonas maltophilia
TMP-SMX: Indications
- Skin and soft tissue infections
- Urinary tract infections (UTIs)
- Meningitis
- Pneumocystis pneumonia
- Toxoplasma encephalitis
TMP-SMX: ADRs
- Gastrointestinal (nausea, vomiting, abdominal discomfort)
- Dermatologic/hypersensitivity
– (Rash, urticaria, Stevens-Johnson syndrome or toxic epidermal necrolysis) - Renal: Caution in renal impairment (dose adjustment needed),
– Crystalluria (need to maintain adequate hydration for prevention) - Hematologic (bone marrow suppression, e.g neutropenia)
TMP/SMX: Other Warning
- DDI: e.g warfaring; enhanced anticoagulant effect
- Cross-allergenicity with other sulfonamide drugs: glipizide, furosemide, hydrochlorothiazide
- Pregnancy catagory C: generally avoided in first trimester and near term
CYCLINE (Tetracyclines)
Introduced in late 1940s
- Basic four-ring chemcial structure with varying structural groups
MOA
Bacteriostatic
- Inhibit bacterial protein synthesis by binding to the 30S bacterial ribosome => preventing access of aminoacyl tRNA to acceptor A site on the mRNA-ribosome complex
Protein synthesis inhibitor
Tetracyclines
Tetracycline (PO)
Doxycycline (Vibramycin, PO and IV)
Minocycline (Minocin, PO, IV):older
Tigecycline (Tygacil, IV): Glycylglycine (minocycline derivative)
Omadacycline (Nuzyra, PO and IV): aminomethylcycline
Eravacycline (Xerava, IV): fluorocycline (similar to tigecycline)
Demeclocyline (PO): NOT USED TO TREAT INFECTIONS
Tetracyclines
Topical indications
- Low-dose doxycycline (Oracea, PO): inflammatory pustules of rosacea
- Extended relase minocycline (Solodyn, PO): acne vugaris
- Sarecycline (Seysara, PO): acne vulgaris
Spectrum of Activity
- Borrelia burgdorferi (lime disease)
- Rickettsia (rocky mountain spotted fever)
- Treponema paallidum
- Chlamydia trachomatis
- Staphylococcus aureus (including MRSA)
- Atypicals: Mycoplasma pneumoniae, Chlamydia spp., Legionella spp.
- OTHER: Yersina pestis (plague), Bacillus anthracis (anthrax), Vibrio
cholerae (cholera), Bartonella henselae (cat scratch disease),
Plasmodium spp. (malaria), Coxiella burnetii (Q fever) - Tetracycline – Helicobacter pylori
- Tigecycline and eravacycline (add) – E. coli, other Enterobacteriaceae,
Bacteroides, and other drug-resistant bacterial strains - Omadacycline (adds) – Streptococcus pneumoniae (drug-resistant
strains), other streptococci, E. coli and other Gram-negative bacteria
Indication
Tetracyclines
- Lyme disease
- Rickettsial (RMSF) and other tickborne infections
- Syphilis
- Chlamydia
- Skin and soft tissue infections
- Community acquired pneumonia
- Complicatied intra abdominal infections
- Other zoonotic infections
Tigecycline BBW
- Increased all cause mortality versus comparators in phase 3 and 4 clinical trials
- Treaatment of hospital acquired pneumonia or ventilatory associated pneumonia